$Organon & Co (OGN.US)$ Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA(R) (tapinarof) Cream, 1% Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA(R) (tapinarof) Cream, 1% The acquisition expands Organon's dermatology capabilities with a nonbiologic, non-steroidal topical treatment in the U.S. BASEL, Switzerland and LONDON and NEW YORK, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Organon (NYSE: OGN), a global health...
$Bank of America (BAC.US)$: ”...You buy some right here, you buy some maybe if it breaks 40. I think this company is selling very inexpensively, and it’s a good one.” $Illumina (ILMN.US)$: “No. No Illumina. I like Danaher.” $Constellation Energy (CEG.US)$: “This is a solar play that is a very good company. It’s up a huge amount versus a lot of other stocks...I think you buy some, please hold on to it, do not sell it.” $Meta Platforms (META.US)$: “I thin...
Organon's low P/E ratio is due to its predicted growth being less than the broader market. Shareholders accept this as they anticipate future earnings won't bring any pleasant surprises. The share price is unlikely to rise significantly soon under these conditions.
Analysts show increased negativity towards the business following recent results, reflected in a minor decrease in next year's EPS estimates. Despite predicted earnings decline, Organon's valuation is not expected to be significantly affected, but growth is anticipated to lag behind the industry.
Seeking Alpha analysts are growing more bullish on the Merck spinoff, despite Wall Street's neutral stance. Analysts Leo Nelissen and Gen Alpha highlight OGN's attractive yield as a reason for their Buy ratings.
Despite the company's payout ratio not posing an immediate concern, the significant decline in earnings per share raises concerns about Organon from a dividend perspective. Therefore, caution is advised for potential investors considering Organon for its upcoming dividend.
U.S. stocks were lower after the close on Tuesday, as losses in the Basic Materials, Financials and Technology sectors led shares lower. At the close in NYSE, the Dow Jones Industrial Average fell 0.45%, while the S&P 500 index lost 0.42%, and the NASDAQ Composite index lost 0.79%. The best performers of the session on the Dow Jones Industrial Average were Amgen Inc ($Amgen (AMGN.US)$), which rose 3.11% or 7.86 points t...
Organon & Co Stock Forum
Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA(R) (tapinarof) Cream, 1%
Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA(R) (tapinarof) Cream, 1%
The acquisition expands Organon's dermatology capabilities with a nonbiologic, non-steroidal topical treatment in the U.S.
BASEL, Switzerland and LONDON and NEW YORK, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Organon (NYSE: OGN), a global health...
🟢 Recently Announced:
⇒ $Organon & Co (OGN.US)$ to acquire Dermavant
⇒ $Rafael Holdings (RFL.US)$ to acquire Cyclo Tx
⇒Crown Lab to acquire $Revance Therapeutics(Delisted) (RVNC.US)$
⇒ $Recursion Pharmaceuticals (RXRX.US)$ merger with Exscientia
🔴 Recently Closed:
⇒ $Johnson & Johnson (JNJ.US)$ acquired V-Wave
⇒ Pharmacosmos acquired $GTHX
What companies will be next? 🤔
$Illumina (ILMN.US)$ : “No. No Illumina. I like Danaher.”
$Constellation Energy (CEG.US)$ : “This is a solar play that is a very good company. It’s up a huge amount versus a lot of other stocks...I think you buy some, please hold on to it, do not sell it.”
$Meta Platforms (META.US)$ : “I thin...
At the close in NYSE, the Dow Jones Industrial Average fell 0.45%, while the S&P 500 index lost 0.42%, and the NASDAQ Composite index lost 0.79%.
The best performers of the session on the Dow Jones Industrial Average were Amgen Inc ( $Amgen (AMGN.US)$ ), which rose 3.11% or 7.86 points t...
Gap Ups
1. $Novo-Nordisk A/S (NVO.US)$ - up 13.4%
2. $Eli Lilly and Co (LLY.US)$ - up 10.5%
3. $James Hardie Industries (JHX.US)$ - up 10.1%
4. $New York Times (NYT.US)$ - up 3.3%
5. $POSCO (PKX.US)$ - up 2.9%
6. $Fox Corp-B (FOX.US)$ - up 2.8%
7. $Fox Corp-A (FOXA.US)$ - up 2.8%
8. $West Pharmaceutical Services (WST.US)$ - up 2.5...
even right now
No comment yet